MedTrace Logo

Facilitated Vegan Diet on Cardiometabolic Endpoints and Trimethylamine N-oxide

NCT05071196 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-04-01

No results posted yet for this study

Summary

Vegan meal kit delivery offers consumer convenience and has shown benefit in cardiometabolic parameters such as low-density lipoprotein cholesterol (LDL-c) and weight. The purpose of this study is to evaluate the impact of meal kit facilitated vegan diet on LDL-c and trimethylamine N-oxide (TMAO) when compared to an omnivorous diet control.

Conditions

  • Cardiometabolic Risk Factors

Interventions

OTHER

Facilitated Vegan Diet

Vegan boxed meal kits

OTHER

Omnivorous Diet

Non-vegan boxed meal kits

Sponsors & Collaborators

  • David Grant U.S. Air Force Medical Center

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071196 on ClinicalTrials.gov